Junling Yang
yangjl@simm.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 2005-09--2010-06 Ph.D.: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 2001-09--2005-06 Bachelor's: Zhejiang University
  • 2014-09~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
  • 2010-07~2014-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
  • 2005-09~2010-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Ph.D. Student
  • 2001-09~2005-06 - Zhejiang University - Bachelor's Student
Pharmacokinetics and Pharmacodynamics of Traditional Chinese Medicine
Research on the Pharmacokinetics of New Chinese Medicines
  • Research on the Compatibility and Detoxification of Toxic Traditional Chinese Medicine Evodia Rutaecarpa, Not mentioned, 2024
  • Composition analysis of compound Shenhua tablet, a seven-herb Chinese medicine for IgA nephropathy: evaluation of analyte-capacity of the assays, Not mentioned, 2024
  • In vitro inhibition of six active sesquiterpenoids in zedoary turmeric oil on human liver cytochrome P450 enzymes, 4th Author, 2024
  • Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2, 12th Author, 2023
  • Pharmacokinetic research of new Chinese medicines, 2nd Author, 2023
  • Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management, 7th Author, 2022
  • Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines, 3rd Author, 2022
  • Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots., Not mentioned, 2020
  • Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions, Not mentioned, 2019
  • Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions, Not mentioned, 2019
Pharmacokinetics Pharmacodynamics Traditional Chinese Medicine New Chinese Medicines Drug Metabolism Herbal Medicine Drug Interactions Ginsenosides Saponins Cytochrome P450

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.